Click the icon below for instructions on downloading the app to your device.
Download the app from the Apple App Store
Viewing this on your mobile device:
Download the app from the Android Market
Viewing this on your desktop:
Please visit the Android Market using your mobile phone and search "Acetadote."
IV Acetadote Dosage Calculator Windows Phone Application Download Process
The IV Acetadote Dosage Calculator supports Windows 5.0-6.5. It does not support Windows Phone 7.
Windows 5.0
Windows 6.0 & 6.1
Windows 6.5
Download the IV Acetadote Dosage Calculator from the Market.
The IV Acetadote Dosage Calculator does not support Windows Phone 7.
Uninstallation for Windows phones:
To Remove the Acetadote Dosage Calculator from your phone:
NOTE:
These instructions do not apply to the iPhone or Android phones.
*Disclaimer:
This program for calculating dosage of Acetadote® is offered as a courtesy and does not supplant or alter the Dosage and Administration information provided in the full Prescribing Information (package insert). For questions referring to Acetadote dosing see full Prescribing Information or call 877-484-2700.
Acetadote, administered intravenously within 8 to 10 hours after ingestion of a potentially hepatotoxic quantity of acetaminophen, is indicated to prevent or lessen hepatic injury.
For maximal protection against hepatic injury, administer Acetadote within 8 hours post-ingestion.
Efficacy diminishes progressively after 8 hours and treatment initiation between 15 and 24 hours post-ingestion of acetaminophen yields limited efficacy.
Acetadote is contraindicated in patients with hypersensitivity or previous anaphylactoid reactions to acetylcysteine or any components of the preparation. Serious anaphylactoid reactions, including death in a patient with asthma, have been reported in patients administered acetylcysteine intravenously.
Acetadote should be used with caution in patients with asthma, or where there is a history of bronchospasm. The total volume administered should be adjusted for patients less than 40 kg and for those requiring fluid restriction. To avoid fluid overload, the volume of diluent should be reduced as needed. If volume is not adjusted, fluid overload can occur, potentially resulting in hyponatremia, seizure, and death.
In the literature, the most frequently reported adverse reactions attributed to IV acetylcysteine administration were rash, urticaria and pruritus. The frequency of adverse reactions has been reported to be between 0.2% and 20.8%, and they most commonly occur during the initial loading dose of acetylcysteine.